Afinion™ HbA1c

MAKE EVERY MINUTE COUNT

全球排名第 1 的 HbA1c 即时检测为您带来即时指导机会

医生诊室通常很繁忙。Abbott 推出的 Afinion™ 即时分析仪能够在几分钟内为糖尿病和糖尿病前期的筛查、诊断和检测提供准确、快速及可靠的结果。即时检测结果可以让医生和患者在就诊时相互借鉴指导,从而有助于提高患者满意度2并减少对随访电话的需求。3

Afinion
Afinion HbA1c Afinion HbA1c Afinion HbA1c

Afinion™ HbA1c

MAKE EVERY MINUTE COUNT

全球排名第 1 的 HbA1c 即时检测为您带来即时指导机会1

医生诊室通常很繁忙。Abbott 推出的 Afinion™ 即时分析仪能够在几分钟内为糖尿病和糖尿病前期的筛查、诊断和检测提供准确、快速及可靠的结果。即时检测结果可以让医生和患者在就诊时相互借鉴指导,从而有助于提高患者满意度2并减少对随访电话的需求。3

及时的临床决策,更好的患者结局

如要控制好糖尿病患者,必须采用包括快速诊断检测在内的综合方法。许多研究将目光聚焦于在临床实践中实施即时检测的潜在优势,并表示可以简化患者管理所涉及的流程、提高时间效率11,12并提升工作人员的满意度。12,15

infographic infographic

及时的临床决策,更好的患者结局

如要控制好糖尿病患者,必须采用包括快速诊断检测在内的综合方法。许多研究将目光聚焦于在临床实践中实施即时检测的潜在优势,并表示可以简化患者管理所涉及的流程、提高时间效率11,12并提升工作人员的满意度。12,15

infographic infographic
详细信息

规格与性能

样本量:1.5 µL

 检测时间:3 分钟

✓ 测量范围:4-15% HbA1c,20-140 mmol/mol

可溯源到 IFCC 参考方法

不受 HbC、HbD、HbE 和 HbS 之类的常见 Hb 变异体的影响。

NGSP 和 IFCC 双重认证

Afinion™ HbA1c 质控品:两级,拆封即用

样本类型:毛细血管血或抗凝静脉血(经过 EDTA、柠檬酸或肝素处理)

 尺寸:25.4cm x 8.1cm x 9.7cm

货号

Afinion™ 系统检测代码
Afinion HbA1c, 15 次测试
1116974 (美国)
Afinion HbA1c, 15 次测试1116797 (NO, SE, DK, FL, IS)
Afinion HbA1c, 15 次测试1116796 (JP)
Afinion HbA1c, 15 次测试1116795 (全球)
Afinion HbA1c 对照品116975 (美国)
Afinion HbA1c 对照品1116793 (全球)
视频
观看视频

观看视频

观看我们奥斯陆工厂生产线的每个流程、全程保证 Afinion 产品的高准确性与可靠性。

专家意见 – Dr.Erna Lenters

专家意见 – Dr.Erna Lenters

观看本次网络研讨会,标题为:即时检测能否实现高准确度?

Dr King 与他的糖尿病患者。

Dr King 与他的糖尿病患者。

聆听来自得克萨斯州圣安东尼奥市的一位客户和糖尿病患者的即时指导的故事。

References

  1. Data on file. Based on 2022 sales data.
  2. Laurence CO, Gialamas A, Bubner T, et al. Patient satisfaction with point-of-care testing in general practice. Br J Gen Pract. 2010;60(572):e98-e104.
  3. Crocker JB, Lee-Lewandrowski E, Lewandrowski N,Baron J, Gregory K, Lewandrowski K. Implementation of point-of-care testing in an ambulatory practice of an academic medical center. Am J Clin Pathol. 2014;142(5):640-646.
  4. Lenters-Westra E, English E. Evaluation of Four HbA1c Point-of-Care Devices Using International Quality Targets: Are They Fit for the Purpose? Journal of Diabetes Science and Technology 2018;12(4):762-770
  5. SKUP. Report from the evaluation SKUP/2021/126. Afinion 2 Analyzer (Abbott Diagnostics Technologies AS), a system for measurement of HbA1c. www.skup.org
  6. Stavelin A et al. Performance of Afinion HbA1c measurements in general practice as judged by external quality assurance data. Clin Chem Lab Med 2020 26;58(4):588-596.
  7. Delatour V et al. Trueness assessment of HbA1c routine assays: are processed EQA materials up to the job? Clin Chem Lab Med 2019;57(10)
  8. Siebelder C. IFCC Report EurA1c 2022: HbA1c Trial EQA organisers. 11 September 2023 https://www.ifcchba1c.org/GeneralInformation.aspx?I=17
  9. NGSP CAP survey data (US) https://ngsp.org/CAPdata.asp
  10. Abbott. Press Release: Abbott launches first-ever rapid point-of-care HbA1c test to aid in the diagnosis of diabetes. Abbott Park, Ill., June 21, 2018. https://www.medicaldevice-network.com/news/abbott-afinion-hba1c-dx-assay/. Accessed May 9, 2024
  11. Lewandrowski EL, Yeh S, Baron J, Crocker B, Lewandrowski K. Implementation of point-of-care testing in a general internal medicine practice: A confirmation study. Clin Chim Acta. 2017;473:71-74.
  12. Patzer K, Ardjomand P, Göhring K et al. Implementation of HbA1c Point of Care Testing in 3 German Medical Practices: Impact on Workflow and Physician, Staff, and Patient Satisfaction. J Diabetes Sci Technol.2018;12:687-694.
  13. Laurence CO, Gialamas A, Bubner T et al. Patient satisfaction with point-of-care testing in general practice. Br J Gen Pract. 2010;60(572): e98–e104.
  14. Smits M, Hopstaken R, Terhaag L et al. Early experiences with quality‑assured HbA1c and professional glucose point‑of‑care testing in general practice: a cross‑sectional observational study among patients, nurses and doctors. BMC Nursing 2022:21:183
  15. Clark SR, Wilson ML. EARLY DIABETES SCREENING IN THE URGENT CARE, PART 2. J Urg Care Med. October 2016.